John Peter Gutfreund

IMDX

John Peter Gutfreund serves as Director at Insight Molecular Diagnostics Inc. (IMDX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

2 trades

$48.0K

Total Sells

0 trades

$0.00

Net Position

Net Buyer

$48.0K

Companies Traded

IMDX

Active Period

Aug 2022 – Dec 2022

2 total trades

Most Recent

Buy IMDX

Dec 28, 2022 · $24.7K

John Peter Gutfreund's Insider Trading at Insight Molecular Diagnostics Inc. (IMDX)

Buys

2 · $48.0K

Sells

0 · $0.00

Total Shares Bought

100,000

Total Shares Sold

IMDX Price Chart

Loading chart...

Date	Type	Shares	Avg Price	Value	Shares After
Dec 28, 2022	Buy	75,000	$0.33	$24.7K	75,000
Aug 17, 2022	Buy	25,000	$0.93	$23.3K	25,000

Related Insiders

BROADWOOD PARTNERS, L.P.

10 percent owner

IMDXBuy · Apr 27, 2026

Explore More Insider Trading Data

IMDX Insider Trading Activity

View all insider trades at Insight Molecular Diagnostics Inc.

Healthcare Sector Insider Trades

See insider activity across healthcare stocks

Latest Insider Buys

Most recent insider purchases across all stocks

CEO Stock Purchases

Track CEO buying activity